10x Genomics Inc (TXG)
27.62
+0.72
(+2.68%)
USD |
NASDAQ |
Apr 26, 16:00
27.62
0.00 (0.00%)
After-Hours: 16:34
10x Genomics Cash from Financing (TTM): 13.67M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 13.67M |
September 30, 2023 | 13.06M |
June 30, 2023 | 10.72M |
March 31, 2023 | 9.986M |
December 31, 2022 | 15.82M |
September 30, 2022 | 19.72M |
June 30, 2022 | 24.36M |
March 31, 2022 | 34.20M |
December 31, 2021 | 35.30M |
Date | Value |
---|---|
September 30, 2021 | 34.10M |
June 30, 2021 | 514.38M |
March 31, 2021 | 506.24M |
December 31, 2020 | 468.91M |
September 30, 2020 | 460.09M |
June 30, 2020 | 388.76M |
March 31, 2020 | 379.85M |
December 31, 2019 | 414.59M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
9.986M
Minimum
Mar 2023
514.38M
Maximum
Jun 2021
196.69M
Average
34.20M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
Teladoc Health Inc | 10.85M |
American Shared Hospital Services | 1.91M |
Novo Integrated Sciences Inc | 4.668M |
Astrana Health Inc | 3.421M |
Cryo-Cell International Inc | -0.7611M |